Crossmark

Indications for hospitalization, clinical course, and mortality analysis among patients with HIV/AIDS in a tertiary care hospital: a 5-year retrospective study (2021–2025)

Crossref DOI link: https://doi.org/10.1186/s12879-026-14560-4

Published Online: 2026-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tahmaz, Alper https://orcid.org/0000-0001-8674-2141
Yildiz Dikmen, Merve https://orcid.org/0009-0000-1090-0166
Ersari, Server Sena https://orcid.org/0009-0004-1918-8477
Dinç, Emine https://orcid.org/0009-0008-2602-4955
Seyman, Derya https://orcid.org/0000-0002-7451-8537
License Information

Text and Data Mining valid from 2026-09-29

Accepted Manuscript valid from 2026-09-29
More Information

Article History

Received: 19 May 2026

Accepted: 25 September 2026

First Online: 29 September 2026

Declarations

Ethics approval and consent to participate: The Scientific Research Ethics Committee of Antalya Training and Research Hospital approved the study on February 5, 2026 (decision no. 03/10; study no. 2026-70). All research data extraction and statistical analyses were conducted after ethics approval. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. Individual informed consent was not required under the institutional provisions for retrospective review of existing records. Direct identifiers were excluded from the analytical dataset.

Consent for publication: Not applicable. The manuscript does not contain any potentially identifying personal information, individual clinical details, or recognizable images of the patients.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below